Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.

@article{Reyngold2014NeoadjuvantRU,
  title={Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.},
  author={Marsha Reyngold and Joyce C. Niland and Anna ter Veer and Dana E Milne and Tanios S. Bekaii-Saab and Steven A. Cohen and Lily Lau Lai and Deborah Schrag and John Michael Skibber and William Small and Martin Weiser and Neal W. Wilkinson and Karyn A. Goodman},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  year={2014},
  volume={12 2},
  pages={235-43}
}
Based on randomized data, neoadjuvant chemoradiotherapy has been incorporated into the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for stage II-III rectal cancer. Factors associated with nonadherence to evidence-based guidelines for neoadjuvant radiotherapy (RT) were examined at dedicated cancer centers. The prospective NCCN Oncology Outcomes Database for Colorectal Cancers was queried for patients with stage II-III rectal cancer who underwent a transabdominal surgical… CONTINUE READING